Activity value 94International Buyer&Supplier,Last transaction date:
2026-05-19Address: 750 corporate dr mahwah, new jersey 07430-2009 united states
Overview
Contact
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for glenmark pharmaceuticals inc. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 1235 transactions, with a transaction quantity of 29928109.41 and a transaction weight of 1446979.22.
YearTransactionsQuantityWeight
20256896175621971.694319549.57
2026123529928109.411446979.22
Bill of lading data
<
1/15
>
Trade date
2026/05/19
B/L No.
yasvbom0080139
Suppliers
glenmark pharmaceuticals inc.
Buyers
glenmark pharmaceuticals inc.
POLs
53313, jawaharlal nehru
PODs
4601, new york/newark area, newark, nj
Product description
41 PACKAGES 1305 CARTONS PHARMACEUTICALS AS UNDER INDOMETHACIN CAP 50MG 100 NDC CODE68462 030201 FDA PRODUCT CODE NO. 62 G C E 42 H. T.S NO. 3004.90.92.40 ANDA NO.91276 THERAPEUTI CE USE ANTIINFLAMATORY ACAMPROSATE CALCIUM D R TAB 333MG 180 NDC CODE68462043518 FDA PRODUCT CODE NO. 60 T C C 99 H. T. S NO. 3004.90.9 2.40 ANDA NO.202229 THERAPEUTICE USE FOR TRE ATING ALCOHOL DEPENDENCE MUPIROCIN OINT 2 22 GM NDC CODE68462018022 FDA PRODUCT CODE NO. 61 G J J 81 H. T. S NO. 3004.90.92.45 ANDA NO.90480 THERAPEUTICE USE ANTIBACTERIAL NORET H ACEEE TAB 10.02MG 63 NDC CODE68462013281 FDA PRODUCT CODE NO.65 J C A 25 H. T. S NO. 3006.60.00.00 ANDA NO.206969 THERAPEUTICE USE S ECONDARY AMENORRHEAENDOMETRIOS IS AND ABNORMAL UTERINE BLEEDING COMMERCIAL CUSTOM INVOIC E NO. F22752000066 DT. 08.04.2026 F22752000067 DT. 08.04.2026 F22752000064 DT. 08.04.2026 F22752000065 DT. 08.04.2026 SBILL NO2253083 DT 09APR2026 SBILL NO2247602 DT 09APR2026 SBILL NO2247608 DT 09APR2026 SBILL NO2253136 DT 09APR2026 GROSS WT.7791.960 KGS NET WT.6132.70 0 KGS 02 DATA LOGGERS HUMIDITY65 SET TEMPERA TURE 18 DEGREES TEMPERATURE XXXXXXXXXXXXXXXX Expand
Trade date
2026/05/17
B/L No.
yasvszz0018173
Suppliers
qilu pharmaceutical hainan co.ltd.
Buyers
glenmark pharmaceuticals inc.
POLs
58201, hong kong
PODs
4601, new york/newark area, newark, nj
Product description
40 PACKAGES 1521 CARTONS PHARMACEUTICALS AS UNDER LEVONORGESTRELEE TAB 0.150.03MG 273 NDC CODE68462067295 FDA PRODUCT CODE NO. 64 G D A 29 H. T. S NO. 3006.60.0000 ANDA NO. 203164THERAPEUTICE USE CONTRACEPTION TO PREVENT P REGNANCY DROSPIRENONEEE TAB 30.02MG 84 NDC C ODE68462072029 FDA PRODUCT CODE NO. 65 J D A 39 H. T. S NO. 3006.60.00.00 ANDA NO. 204296 THERAPEUTICE USE ORAL CONTRACEPTIVE COMMERC IAL CUSTOM INVOICE NO. XXXXXXXXXXXX DT. 19.0 3.2026 F22652006580 DT. 20.03.2026 SBILL NO 1667280 DT 20MAR2026 SBILL NO 1689594 DT 21MAR2026 GROSS WT.5018.430 KGS NET WT.3622.610 K GS 02 DATA LOGGERS HUMIDITY65 SET TEMPERATUR E 20 DEGREES TEMPERATURE RANGE 15 DEGREES T O 25 DEGREES NOTIFY PARTY2 XXXXXXXXXXXXXXXXX HWAH 07430 USA Expand
Trade date
2026/05/08
B/L No.
maeu267809580
Suppliers
anthea pharma pvt ltd.
Buyers
glenmark pharmaceuticals inc.
POLs
52330, salalah
PODs
4601, new york/newark area, newark, nj
Product description
PART OF FCL 10 PACKAGES 373 CARTONS PHARMACE UTICALS AS UNDER 8.4 SODIUM BICARBONATE INJE CTION USP 50 MEQ50 ML (1 MEQML) (25S PACK) NDC CODE 68462095165 HTS 3004.90.9266 FDA CODE 65RCK18 ANDA 219701 COMMERCIAL CUSTOM INV OICE NO. INVXXXXXXXXX DT. 20.03.2026 SBILL N O 1689159 DT 21MAR2026 GROSS WT.4987.035 KGS NET WT.1945.568 KGS 02 DATA LOGGERS HUMIDIT Y65 SET TEMPERATURE 18 DEGREES TEMPERATURE R ANGE 15 DEGREES TO 25 DEGREES NOTIFY PARTY2 GLENMARK PHARMACEUTICALS INC. USA XXXXXXXXXXX Expand
Trade date
2026/05/08
B/L No.
maeu268660323
Suppliers
glenmark pharmaceuticals inc.
Buyers
glenmark pharmaceuticals inc.
POLs
52330, salalah
PODs
4601, new york/newark area, newark, nj
Product description
PART OF FCL 6 PACKAGES 388 CARTONS PHARMACEU TICALS AS UNDER ABIRATERONE ACE TAB 250MG 12 0 NDC CODE68462013508 FDA PRODUCT CODE NO. 62Z C A 40 H. T. S NO. 2937.21.00 ANDA NO.2092 27 THERAPEUTICE USE INDICATED IN COMBINATION WITH PREDNISONE FOR THE TREATMENT OF PATIENTSWITH METASTATIC CASTRATIONRESISTANT PROSTAT E CANCER (CRPC) ABIRATERONE ACE TAB 500MG 60 NDC CODE68462088260 FDA PRODUCT CODE NO. 62 Z C A 40 H. T. S NO. 2937.21.00 ANDA NO.209227 THERAPEUTICE USE INDICATED IN COMBINATION WITH PREDNISONE FOR THE TREATMENT OF PATIENTS WITH METASTATIC CASTRATIONRESISTANT PROSTATE CANCER (CRPC) COMMERCIAL CUSTOM INVOICE NO . F22600003278 DT. 23.03.2026 F22600003289 DT . 24.03.2026 GROSS WT. 1445.226 KGS NET WT.1 210.492 KGS 06 DATA LOGGERS HUMIDITY65 SET T EMPERATURE 18 DEGREES TEMPERATURE RANGE 15 DEGREES TO 25 DEGREES SBILL NO 1823039 DT 26 MAR2026 SBILL NO 1826187 DT 26MAR2026 NOTIFY PARTY2 XXXXXXXXXXXXXXXXXXXXXXX XXXXXXXXXXX ( GSSA) PLACE DU PORT 2 NEUCHATEL 2000 SWITZER LAND Expand
glenmark pharmaceuticals inc. is International Buyer&Supplier,
and primarily engages in the import and export business of products such as bat,pharmaceutical,cap.
According to the 52wmb.com global trade database, as of 2026-05-19, the company has completed 382268 international trades,
with its main trading regions covering india,other,united states etc.
The core products include HS30049099,HS30049034,HS30049081 etc,
often transported via new york,port newark nj, port sahar air cargo acc inbom4 etc,
and its main trading partners are glenmark pharmaceuticals inc.,lageen tuboplast ltd,glenmark generics ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on glenmark pharmaceuticals inc. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.